In addition, allergy immunotherapy led to a significant decrease in ER stress and PERK/CHOP signaling, increasing CD4+CD25+Foxp3+ Treg cells, and ameliorated airway hyper-responsiveness and airway inflammation. This evidence concerns the gene EIF2AK3 and allergic disease.